Newborn Screening Updates

View Letter to Providers Regarding Fee Increase

Date: May 19, 2025

From: University of Iowa, State Hygienic Laboratory

RE: Fee Increase

Dear Newborn Screening Participant,

Since June 1, 2007 the South Dakota Department of Health (SDDOH), Division of Family and Community Health, has contracted with the State Hygienic Laboratory at the University of Iowa (SHL) to provide Newborn Screening (NBS) laboratory services for the South Dakota Newborn Screening Program (SDNSP). All laboratory testing required by the SDNSP is performed at the SHL NBS laboratory located in Ankeny, Iowa.

An increase in the NBS fee to $119.42, from the current fee of $106, has been approved by SDDOH to help cover increased annual costs including follow-up services. This fee increase goes into effect on specimens received by the SHL NBS laboratory on July 1, 2025.

The SHL NBS laboratory performs testing 365 days a year and has expanded hours of operation that allow for processing of specimens throughout the night. SHL contracts with Same Day Express, Inc. to provide courier service for SD NBS specimens from collection site to the SHL NBS laboratory. In most cases, NBS specimens picked up by early afternoon in SD will be delivered to the SHL NBS laboratory by 1:30AM the following morning where processing will begin immediately.

We look forward to our ongoing collaboration with you in this important, life saving work of newborn screening. Thank you for your continuing efforts to protect the health of South Dakota’s newborns.

For questions regarding General NBS laboratory:

Valerie Phoenix
Phone: 319-335-0052 

For questions regarding supplies and courier service:

Sierra Daniels
Phone: 515-725-1630

For questions regarding billing:

John Negley
Phone: 319-335-4442

For questions regarding South Dakota's Newborn Screening Program:

Kristy Jackson, CYSHN Director, South Dakota Department of Health
Phone: 605-910-7091
Email: Kristy.jackson@state.sd.us

View Letter to Providers Regarding Screening Updates

Date: May 6, 2024

From:  South Dakota Department of Health, Newborn Screening Program and State Hygienic Laboratory at the University of Iowa 

RE: IMPLEMENTATION OF TESTING FOR A NEW DISORDER FOR NEWBORN SCREENING

Screening for X-ALD and Hearing will begin June 3, 2024

On April 15, 2024, the South Dakota Department of Health Newborn Screening Program received approval through the administrative rule process to begin screening for X-linked adrenoleukodystrophy (X-ALD) as well as require newborn hearing screening as part of the newborn screening program.
 
Upon the adoption of the proposed Administrative Rule that includes the addition of X-ALD to the South Dakota Newborn Screening panel, the South Dakota Department of Health Newborn Screening Program will begin screening for X-ALD through the Iowa State Hygienic Laboratory’s screening process on June 3, 2024. Additionally, all babies born in South Dakota will be required to have an initial hearing screening before leaving the hospital or by one month of age, also effective on June 3, 2024.

Effective June 3, 2024, all newborns born in South Dakota will be screened for X-ALD and hearing.

What is X-ALD?

Adrenoleukodystrophy (X-ALD) is a rare, X-linked disease caused by a genetic mutation, and is more common in males than females. As a metabolic disease, X-ALD can lead to adrenal problems and potentially to more serious complications if not managed.  There are three distinct presentations of X-ALD, which differ in regard to disease severity and age of onset. The symptoms and long-term outcome of each form vary widely.

To screen for X-ALD, laboratories use a machine called a tandem mass spectrometer to measure how much of the Very Long Chain Fatty Acids (VLCFA) is in the dried blood spots. High levels of VLCFAs mean a higher risk for X-ALD. When a newborn has high VLCFA levels, the baby needs more tests. The newborn screening program works with the baby’s doctor to ensure the baby receives additional tests and/or visits a specialist to confirm if the baby had X-ALD.

As a reminder, this is a screening test. A false negative or a false positive result must always be considered when screening. Therefore, clinical findings and status should be considered whenever interpreting laboratory results. 

Notice of X-ALD Pilot: During the time between June 3 and November 1, we want to be sure all components of the NBS system for X-ALD are not only in place but functioning effectively.   During this time, the X-ALD results will not be reported.  However, if there is a screen-positive result, the results will be communicated to the SD Newborn Screening Follow-Up staff, and they will proceed with their protocols consistent with how abnormal results are handled for the other NBS conditions being screened for.  The lab intends to formally begin reporting X-ALD results starting November 1, 2024. 

Purpose and Standard for Newborn Hearing Screening

Congenital hearing loss is the most common birth anomaly, affecting three in every 1,000 births in South Dakota.  Hearing loss or deafness can occur when any parts of the ear are not working in the proper way. Hearing loss can affect a child’s ability to develop speech, language, and social skills. However, with early identification and intervention, children with hearing loss are less likely to experience these challenges. Hearing tests can identify problems early so that children with hearing loss can be treated and get the help they need as soon as possible. The CDC’s benchmark is that 95% of infants will receive an initial hearing screen by 1 month of age.  Infants who do not pass the hearing screen with both ears should have a diagnostic audiology exam by 3 months of age.
Hearing screening for newborns can measure hearing without needing the child to cooperate or can be done while the child is sleeping.  For example:

• Automated auditory brainstem (aABR) tests check the inner ear, the hearing nerve, and parts of the brain that are involved with hearing. These measure how the brain responds to the sounds.
• Otoacoustic emissions (OAE) tests check for damage in the hair cells in the cochlea. If the test shows little or no OAEs, a child may have sensorineural hearing loss.

Newborns and infants may "pass" or "refer" a hearing screening. Infants who “refer” in one or both ears need to be sent to a pediatric audiologist for a diagnostic exam no later than 3 months of age. See https://EHDIPALS.org for pediatric audiology providers in the state.

Both hearing screening and hearing diagnostic results should be reported to the South Dakota Department of Health Newborn Screening Program via the South Dakota Department of Health Electronic Vital Records and Screening System (EVRSS). Providers who do not have access to the EVRSS system may use this form.

Since hearing loss may be associated with other health conditions, other referrals should be considered like ophthalmology and genetics.

Early intervention services are recommended for infants identified as deaf or hard of hearing no later than 6 months of age. Interventions may be medical, audiologic, or educational, including a range of assistive hearing technologies and communications modalities.

Referrals should be made to the South Dakota Department of Education Birth to Three Early Intervention Program.

Infants who pass their newborn hearing screening can develop hearing loss at any point after birth, especially those with risk factors. Continue screening throughout childhood per AAP guidelines.

If a parent/caregiver refuses the newborn hearing screening a refusal form must be completed and submitted to the South Dakota Department of Health Newborn Screening Program.

Education for Providers and Families

In the coming weeks, revised brochures will be available for medical providers to order through the South Dakota Department of Health website.  In the meantime, these details may be of interest to your practice:

X-ALD:

• The newborn screening fee for the bloodspot panel will increase from the current rate of $98.00 to $106 on November 1, 2024, after the X-ALD pilot period.
• There will be no charge for repeat specimens when requested by the South Dakota Department of Health or the State Hygienic Laboratory.
• Please check with your billing office regarding the CPT code that your facility will use for the newborn screening panel. The code for the newborn screening panel is S3620.
• Bloodspot specimen collection will not change from current procedures - nothing different needs to be done for the collection of the newborn blood spot specimen.
• Additional X-ALD information is available upon request.  If interested, please contact the South Dakota Department of Health Newborn Screening Program at 1-800-738-2301.
• X-ALD information is also available from the US National Library of Medicine and Baby’s First Test 

Hearing:

• The required newborn hearing screen may or may not impact how your facility chooses to bill for this service. Common practices include the use of CPT codes 92558, 92588 and 92650.
• Newborn hearing screening results are shared with the SD Department of Health via entering them directly through the birth certificate process.
• A parental refusal form is available on the DOH website.  Facilities using other forms for refusal documentation will need to update their forms to account for hearing screens.
• Newborn Hearing Screening information is also available from:
  • Baby’s First Test
  • Joint Committee on Infant Hearing
  • American Academy of Pediatrics (AAP)
    • AAP Article

The South Dakota Department of Health and the State Hygienic Laboratory intend to work closely with you to implement X-ALD and hearing status screening to save lives and improve outcomes for affected infants. Please feel free to contact us with any questions regarding these screens. 

For questions about the South Dakota Newborn Screening Program, please contact:

Amanda Peterson, Newborn Screening Coordinator
Phone: 605-312-0978  
Email: amanda.peterson@sanfordhealth.org

For questions related to screening follow-up and treatment:

Abby Seydel, Newborn Screening Program Specialist
Phone: 605-312-0976
Email:  Abby.Seydel@sanfordhealth.org

For laboratory-related questions, please contact:

Kenneth Coursey, Manager – Newborn Screening Laboratory
Phone: 319-335-467-1022
Email: kenneth-coursey@uiowa.edu

For newborn hearing screening-related questions, please contact:

Shelby Jepperson, Project Director, South Dakota HRSA EHDI Grant 
Phone:  605-357-1544
Email: Shelby.Jepperson@usd.edu

For all other questions, please contact:

Kristy Jackson, CYSHN Director, South Dakota Department of Health
Phone: 605-910-7091
Email: Kristy.jackson@state.sd.us

The South Dakota Department of Health, Office of Child and Family Services is pleased to announce the Newborn Screening Program will be expanding its service to include long-term follow-up for diagnosed disorders identified by newborn screening bloodspot testing. This expanded service will be located at Sanford Children’s Specialty Clinic in Sioux Falls, SD.

The Sanford long-term follow-up team will provide care coordination, insight, primary care and specialist communication, support, and referral services to various state and private programs for newborn screening patients and parents. 

The children covered by this service must be a residents of South Dakota and have a disorder found on our screening panel. The program will assist families across all medical institutions and is not limited to Sanford Health System.

Beginning August 1, 2023, the Sanford long-term follow-up program will begin reaching out to physicians and families to enroll our smallest residents. There is no cost to families for this program.

Find more information about Newborn Screening and the disorders included on the newborn screening panel. For additional questions about Newborn Screening and the Long-Term Follow-up program please contact the Newborn Screening Program at DOHNewbornScreening@state.sd.us. 

The National Collegiate Athletic Association (NCAA) requires all athletes at Division I and II schools to be tested for sickle cell trait before competing or to sign a written release declining the test. The South Dakota Newborn Screening Program does not provide newborn screening test results.

Newborn screening results may be obtained by contacting the athlete's hospital of birth or their Primary Care Provider (PCP).

Other options for NCAA athletes to obtain proof of Sickle Cell trait include:

• Requesting a hemoglobin electrophoresis test as part of the sports physical.

• Discussing other means of obtaining this test with the college athletic department.

For further information about the collegiate athletic requirement for documentation of sickle cell trait testing, please visit the NCAA website.

IMPLEMENTATION OF TESTING FOR A NEW DISORDER FOR NEWBORN SCREENING

SCREENING FOR POMPE

Effective September 1, 2022
Pompe (Glycogen Storage Disease Type II)
ADDED TO SOUTH DAKOTA NEWBORN SCREENING PANEL

In consultation with the South Dakota Newborn Screening Advisory Committee, the South Dakota Department of Health has added Pompe (Glycogen Storage Disease Type II) to South Dakota's newborn screening panel.

Early treatment of babies with infantile-onset Pompe is needed to avoid progressive, fatal cardiomyopathy. Without treatment, the infantile form of Pompe disease typically leads to death within the first two years of life.

What is Pompe Disease?

Pompe Disease is an inherited autosomal recessive condition that results in progressive myopathy of both skeletal and cardiac muscle. In the infantile-onset form, severe symptoms may be present within two weeks of life and most children are symptomatic by one year of age. Late-onset Pompe includes infants less than twelve months old without cardiomyopathy or children with symptoms starting after they are one year old.

Newborn screening for Pompe involves the measurement of acid-a-glucosidase (GAA) enzyme activity using Flow Injection Analyses-Tandem Mass Spectrometry (FIA-MS/MS). A screen-positive result for Pompe is detected by a low or absent activity of the GAA enzyme, the biomarker for Pompe disease.

As a reminder, this is a screening test. A false negative or a false positive result must always be considered when screening. Therefore, clinical findings and status should be considered when interpreting laboratory results.

• The newborn screening fee will increase from the current rate of $91.00 to $98.00 on September 1, 2022.

• There will be no charge for repeat specimens when requested by the South Dakota Department of Health or the State Hygienic Laboratory.

• The CPT procedure and service code used for the Newborn Screening panel, including Pompe disease screening, is S3620. This is a universal code and is the only code to use per APP and HIPPA.

HCPCS Level II codes are part of the standard procedure code set under the Health Insurance Portability and Accountability Act of 1996.

The newborn metabolic screening panel, includes the test kit, postage, and the laboratory tests specified by the state for inclusion in this panel (eg, galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-D; phenylalanine [phenylketonuria (PKU)]; and thyroxine, total)

• NOTE: The appropriate blood collection code (36416). DO NOT bill for each test separately

• Specimen collection will not change from current procedures - nothing different needs to be done for the collection of the newborn blood spot specimen.

• Additional Pompe disease information is available upon request. If interested, please contact the South Dakota Department of Health Newborn Screening Program at 605-983-1389. Pompe disease information is also available from the US National Library of Medicine and Baby’s First Test.

Questions regarding Pompe disease screening may be directed to the following individuals:

Questions for the South Dakota Newborn Screening Program:

Bernadette Boes, RN
Newborn Screening Program Coordinator
South Dakota Department of Health
605-983-1389
Bernadette.boes@state.sd.us

SHL Newborn Screening Laboratory Questions:

Kenneth Coursey
Clinical Lab Supervisor, SHL Newborn Screening Laboratory
515-725-1630
kenneth-coursey@uiowa.edu

SHL Newborn Screen Billing Questions:

John Negley
State Hygienic Laboratory
2490 Crosspark Road
Coralville, IA 52241
319-335-4500/Fax 319-335-4171
shl-receivable@uiowa.edu

Screening Follow-up and Treatment Questions:

Sharina Tveit, RN
South Dakota Newborn Screening Program
Follow-up Coordinator
605-312-0976
Sharina.tveit@sanfordhealth.org

The South Dakota Department of Health and the State Hygienic Laboratory intend to work closely with you to implement screening for Pompe disease with the goal of saving lives and improving outcomes for affected infants. Please feel free to contact us with any questions regarding Pompe disease screening.

Sincerely,

Beth Dokken
Division Director, Division of Family & Community Health
South Dakota Department of Health
605-773-3737
Beth.dokken@state.sd.us

Ken Coursey
Clinical Lab Supervisor, NBS Laboratory
Iowa State Hygienic Laboratory
515-725-1628
kenneth-coursey@uiowa.edu